After Delpharm bought the Boucherville plant in 2022, Sandoz signed an exclusive partnership with the company to maintain its ...

Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz, saying a key provision ...

said Sandoz in a statement. Patents for denosumab expired in some European markets in June, although the drug is still protected in France, Italy, Spain, and the UK until 2025, when exclusivity ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first financial year as an independent company. After completing its spin-off from ...

Your doctor has weighed the risks of you taking Cyclosporin Sandoz against the benefits they expect it will have for you. If you have any concerns about taking this medicine, ask your doctor or ...

Sandoz signed a partnership with the company to maintain its supply of sterile injectables for Canadian hospitals.

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market ... Samsung subsequently contracted with Sandoz to market the treatment, which is named Pyzchiva, in ...

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on ...

Sabki, Head of the General Authority for Health Care, met with Dr Samah Al-Bagouri, Chairman of the Board of Directors of ...

A cost-saving effort by NHS England to transition multiple sclerosis (MS) patients from Biogen Inc’s (NASDAQ:BIIB) Tysabri (natalizumab) to the biosimilar drug Tyruko has led to significant side ...